Amphera Overview

  • Founded
  • 2012
  • Status
  • Private
  • Employees
  • 3
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $6.6M
Latest Deal Amount
  • Investors
  • 3

Amphera General Information


Developer of immunotherapy intended to help in the treatment of cancer. The company's immunotherapy is developed by using dendritic cells to treat malignant mesothelioma and other cancers induced by asbestos, providing patients with alternatives to chemotherapy and improving their quality of life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Primary Office
  • Onderwijsboulevard 225
  • 5223 DE 's-Hertogenbosch
  • Netherlands
+31 073 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Amphera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 01-Jan-2019 $6.6M 00000 Completed Generating Revenue
2. Debt - General 13-Mar-2014 00000 00000 Completed Generating Revenue
1. Seed Round 01-Mar-2014 Completed Generating Revenue
To view Amphera’s complete valuation and funding history, request access »

Amphera Executive Team (3)

Name Title Board Seat Contact Info
Rob Meijer Chief Executive Officer
Tomasz Knurowski MD Chief Medical Officer
Ilona Enninga Ph.D Chief Operating Officer
To view Amphera’s complete executive team members history, request access »

Amphera Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Amphera Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Horizon 2020 Government 000 0000 000000 0
Brabant Life Sciences Seed Fund Venture Capital Minority 000 0000 000000 0
Lupus Ventures Venture Capital Minority 000 0000 000000 0
To view Amphera’s complete investors history, request access »